Hollencrest Capital Management Grows Stock Holdings in Intuitive Surgical, Inc. (NASDAQ:ISRG)

Hollencrest Capital Management lifted its position in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 0.8% in the third quarter, HoldingsChannel.com reports. The firm owned 4,377 shares of the medical equipment provider’s stock after purchasing an additional 33 shares during the period. Hollencrest Capital Management’s holdings in Intuitive Surgical were worth $2,150,000 at the end of the most recent quarter.

Other large investors also recently modified their holdings of the company. Ridgewood Investments LLC bought a new stake in shares of Intuitive Surgical in the 2nd quarter worth approximately $26,000. Godsey & Gibb Inc. raised its stake in Intuitive Surgical by 140.0% in the third quarter. Godsey & Gibb Inc. now owns 60 shares of the medical equipment provider’s stock worth $29,000 after buying an additional 35 shares in the last quarter. Creekmur Asset Management LLC lifted its holdings in Intuitive Surgical by 200.0% in the first quarter. Creekmur Asset Management LLC now owns 63 shares of the medical equipment provider’s stock worth $25,000 after buying an additional 42 shares during the period. LGT Financial Advisors LLC lifted its stake in shares of Intuitive Surgical by 415.4% in the 2nd quarter. LGT Financial Advisors LLC now owns 67 shares of the medical equipment provider’s stock valued at $30,000 after purchasing an additional 54 shares during the period. Finally, Delos Wealth Advisors LLC boosted its position in shares of Intuitive Surgical by 380.0% during the first quarter. Delos Wealth Advisors LLC now owns 72 shares of the medical equipment provider’s stock valued at $29,000 after purchasing an additional 57 shares in the last quarter. 83.64% of the stock is owned by institutional investors.

Analyst Ratings Changes

A number of research analysts recently weighed in on the company. Piper Sandler reaffirmed an “overweight” rating and set a $538.00 price objective (up previously from $495.00) on shares of Intuitive Surgical in a research report on Friday, October 18th. The Goldman Sachs Group set a $604.00 price target on Intuitive Surgical in a research report on Friday, October 18th. Redburn Atlantic upgraded shares of Intuitive Surgical from a “neutral” rating to a “buy” rating and raised their price objective for the company from $380.00 to $510.00 in a research note on Friday, August 2nd. Barclays boosted their price objective on shares of Intuitive Surgical from $430.00 to $490.00 and gave the stock an “overweight” rating in a report on Thursday, July 18th. Finally, Wells Fargo & Company upped their price target on Intuitive Surgical from $466.00 to $549.00 and gave the company an “overweight” rating in a report on Friday, October 18th. One investment analyst has rated the stock with a sell rating, five have issued a hold rating and fourteen have assigned a buy rating to the stock. According to data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and a consensus target price of $513.74.

Insider Buying and Selling

In other Intuitive Surgical news, EVP Robert Desantis sold 240 shares of the firm’s stock in a transaction dated Monday, August 12th. The stock was sold at an average price of $464.76, for a total transaction of $111,542.40. Following the sale, the executive vice president now directly owns 5,506 shares of the company’s stock, valued at $2,558,968.56. This trade represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. In other Intuitive Surgical news, EVP Robert Desantis sold 240 shares of Intuitive Surgical stock in a transaction on Monday, August 12th. The shares were sold at an average price of $464.76, for a total value of $111,542.40. Following the sale, the executive vice president now directly owns 5,506 shares in the company, valued at approximately $2,558,968.56. The trade was a 0.00 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which is accessible through this link. Also, CEO Gary S. Guthart sold 18,151 shares of the stock in a transaction that occurred on Wednesday, October 30th. The shares were sold at an average price of $511.63, for a total value of $9,286,596.13. Following the transaction, the chief executive officer now directly owns 24,219 shares of the company’s stock, valued at approximately $12,391,166.97. The trade was a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last quarter, insiders sold 68,246 shares of company stock valued at $33,839,308. Company insiders own 0.90% of the company’s stock.

Intuitive Surgical Trading Up 2.2 %

NASDAQ ISRG traded up $11.76 on Friday, reaching $536.04. 331,070 shares of the stock were exchanged, compared to its average volume of 1,451,581. The firm has a market capitalization of $190.93 billion, a PE ratio of 84.29, a PEG ratio of 4.99 and a beta of 1.39. Intuitive Surgical, Inc. has a one year low of $269.49 and a one year high of $536.39. The company’s 50-day simple moving average is $492.30 and its two-hundred day simple moving average is $450.05.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.